Diabetes Depresses Synaptic Transmission in Sympathetic Ganglia by Inactivating nAChRs through a Conserved Intracellular Cysteine Residue

Neuron

Volumn 66, Issue 6, 2010, Pages 827-834

  Campanucci, Verónica ^a   Krishnaswamy, Arjun ^a   Cooper, Ellis ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cellbio; Humdisease; Sysneuro

Indexed keywords

CYSTEINE; NICOTINIC RECEPTOR; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DYSAUTONOMIA; HYPERGLYCEMIA; MOUSE; NERVE CELL CULTURE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SYMPATHETIC GANGLION; SYMPATHETIC NERVE CELL; SYMPATHETIC REFLEX; SYNAPTIC TRANSMISSION;

ACETYLCHOLINE; ADENOVIRIDAE; AGE FACTORS; ALDEHYDES; ANIMALS; ANIMALS, NEWBORN; BODY TEMPERATURE; CELLS, CULTURED; CYSTEINE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUCOSE; GUANIDINES; HEART RATE; HYPOGLYCEMIC AGENTS; INSULIN; LEPTIN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; OXIDATIVE STRESS; PATCH-CLAMP TECHNIQUES; REACTIVE OXYGEN SPECIES; RECEPTORS, LEPTIN; RECEPTORS, NICOTINIC; SENSORY RECEPTOR CELLS; SUPERIOR CERVICAL GANGLION; SYNAPTIC TRANSMISSION;

EID: 77953957578     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2010.06.010     Document Type: Article

References (31)

1. Axelsson J. Catecholamine functions. Annu. Rev. Physiol. 1971, 33:1-30.
2. Bachman E.S., Dhillon H., Zhang C.Y., Cinti S., Bianco A.C., Kobilka B.K., Lowell B.B. betaAR signaling required for diet-induced thermogenesis and obesity resistance. Science 2002, 297:843-845.
3. Campanucci V.A., Krishnaswamy A., Cooper E. Mitochondrial reactive oxygen species inactivate neuronal nicotinic acetylcholine receptors and induce long-term depression of fast nicotinic synaptic transmission. J. Neurosci. 2008, 28:1733-1744.
4. Chen H., Charlat O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J., Lakey N.D., Culpepper J., Moore K.J., Breitbart R.E., et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996, 84:491-495.
5. Coleman D.L. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978, 14:141-148.
6. de Arriba S.G., Stuchbury G., Yarin J., Burnell J., Loske C., Münch G. Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells-protection by carbonyl scavengers. Neurobiol. Aging 2007, 28:1044-1050.
7. Duby J.J., Campbell R.K., Setter S.M., White J.R., Rasmussen K.A. Diabetic neuropathy: an intensive review. Am. J. Health Syst. Pharm. 2004, 61. 160-173, quiz 175-176.
8. Dyck P.J., Kratz K.M., Karnes J.L., Litchy W.J., Klein R., Pach J.M., Wilson D.M., O'Brien P.C., Melton L.J., Service F.J. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993, 43:817-824.
9. Freeman R. Autonomic peripheral neuropathy. Lancet 2005, 365:1259-1270.
10. Hammes H.P., Martin S., Federlin K., Geisen K., Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc. Natl. Acad. Sci. USA 1991, 88:11555-11558.
11. Junod A., Lambert A.E., Stauffacher W., Renold A.E. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J. Clin. Invest. 1969, 48:2129-2139.
12. Klein C.M., Vernino S., Lennon V.A., Sandroni P., Fealey R.D., Benrud-Larson L., Sletten D., Low P.A. The spectrum of autoimmune autonomic neuropathies. Ann. Neurol. 2003, 53:752-758.
13. Krishnaswamy A., Cooper E. An activity-dependent retrograde signal induces the expression of the high-affinity choline transporter in cholinergic neurons. Neuron 2009, 61:272-286.
14. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008, 51:216-226.
15. Low P.A. Autonomic neuropathies. Curr. Opin. Neurol. 2002, 5:605-609.
16. McFarlane S., Cooper E. Postnatal development of voltage-gated K currents on rat sympathetic neurons. J. Neurophysiol. 1992, 67:1291-1300.
17. Poth K., Nutter T.J., Cuevas J., Parker M.J., Adams D.J., Luetje C.W. Heterogeneity of nicotinic receptor class and subunit mRNA expression among individual parasympathetic neurons from rat intracardiac ganglia. J. Neurosci. 1997, 17:586-596.
18. Rassadi S., Krishnaswamy A., Pié B., McConnell R., Jacob M.H., Cooper E. A null mutation for the alpha3 nicotinic acetylcholine (ACh) receptor gene abolishes fast synaptic activity in sympathetic ganglia and reveals that ACh output from developing preganglionic terminals is regulated in an activity-dependent retrograde manner. J. Neurosci. 2005, 25:8555-8566.
19. Schmidt R.E. Neuropathology of human sympathetic autonomic ganglia. Microsc. Res. Tech. 1996, 35:107-121.
20. Schmidt R.E. Age-related sympathetic ganglionic neuropathology: human pathology and animal models. Auton. Neurosci. 2002, 96:63-72.
21. Schmidt R.E., Parvin C.A., Green K.G. Synaptic ultrastructural alterations anticipate the development of neuroaxonal dystrophy in sympathetic ganglia of aged and diabetic mice. J. Neuropathol. Exp. Neurol. 2008, 67:1166-1186.
22. Tomlinson D.R., Gardiner N.J. Glucose neurotoxicity. Nat. Rev. Neurosci. 2008, 9:36-45.
23. Vernino S., Low P.A., Fealey R.D., Stewart J.D., Farrugia G., Lennon V.A. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N. Engl. J. Med. 2000, 343:847-855.
24. Vernino S., Sandroni P., Singer W., Low P.A. Invited Article: Autonomic ganglia: target and novel therapeutic tool. Neurology 2008, 70:1926-1932.
25. Vernino S., Hopkins S., Wang Z. Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy. Auton. Neurosci. 2009, 146:3-7.
26. Vinik A.I., Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007, 115:387-397.
27. Vinik A.I., Freeman R., Erbas T. Diabetic autonomic neuropathy. Sem. Neurobiol. 2003, 23:365-372.
28. Webster J., Urban C., Berbaum K., Loske C., Alpar A., Gärtner U., de Arriba S.G., Arendt T., Münch G. The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal. Neurotox. Res. 2005, 7:95-101.
29. Xu W., Gelber S., Orr-Urtreger A., Armstrong D., Lewis R.A., Ou C.N., Patrick J., Role L., De Biasi M., Beaudet A.L. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA 1999, 96:5746-5751.
30. Yao D., Taguchi T., Matsumura T., Pestell R., Edelstein D., Giardino I., Suske G., Rabbani N., Thornalley P.J., Sarthy V.P., et al. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J. Biol. Chem. 2007, 282:31038-31045.
31. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.